• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Bill Lands Video - PUFAs


  • Please log in to reply
109 replies to this topic

#91 oehaut

  • Guest
  • 393 posts
  • 20
  • Location:Canada

Posted 19 April 2010 - 11:43 PM

I thought this was a very interesting discussion related to trans-fat between taka and monty:
Trans fat for longevity


Interesting, indeed. What do you think of what he says? Could trans-fat, even industrial, really could not be so bad?


There is strong epidemiological evidence against trans fats, stronger than there is against any other kind of fat. So, to claim it's confounding, you need to come up with a something that wasn't independently measured that is strongly associated with trans fat consumption. I can't think of anything. Trans fats also adversely effect certain surrogate markers, like cholesterol. But the surrogate markers are based on a flawed model, so that's not conclusive either... Would it surprise me if trans fats weren't as bad as everything thinks? Yes, but it's not beyond imagination. They are stable.



Don't know if this could be a counfonding factor, as monty 1 says it here

However, will you hear about this study in the "mainstream media?" Or will you hear yet another report about how "bad" "trans fats" are, with either no evidence cited or else an "epidemiological" study cited that did not control for lipid peroxidation (in other words, what most likely happens when "trans fat" appears to be unhealthy is that those who ate the most TFAs also ate the most PUFAs and/or had a diet significantly lower in antioxidant-rich foods).



#92 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 20 April 2010 - 06:34 AM

There's a couple of interesting papers on this site:

ISSFAL - fatty acids, lipids and health studies

And some other studies:

Journal of Lipid Research, Vol. 47, 1812-1822, August 2006
Low liver conversion rate of -linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet
Miki Igarashi1, Kaizong Ma, Lisa Chang, Jane M. Bell, Stanley I. Rapoport and James C. DeMar, Jr

American Journal of Clinical Nutrition, Vol. 84, No. 1, 44-53, July 2006
Conversion of -linolenic acid in humans is influenced by the absolute amounts of -linolenic acid and linoleic acid in the diet and not by their ratio
Petra LL Goyens, Mary E Spilker, Peter L Zock, Martijn B Katan and Ronald P Mensink

I've read MR's analysis of ALA's conversion to LC n-3's a while a go and from what I remember checking the references it made sense at the time. However the more I read the less appealing ALA seems. But these are done in rats. Anyone have human studies?

sponsored ad

  • Advert
Click HERE to rent this advertising spot for NUTRITION to support LongeCity (this will replace the google ad above).

#93 tunt01

  • Topic Starter
  • Guest
  • 2,308 posts
  • 414
  • Location:NW

Posted 20 April 2010 - 11:59 AM

What is the correct ratio? I've been taking carnosine, but I'm thinking of switching to beta-alanine based on cost.



don't know. putting it on my list of things to do. might look it up this saturday.

#94 TheFountain

  • Guest
  • 5,362 posts
  • 257

Posted 20 April 2010 - 12:51 PM

What is this non-sense about Almonds also? Almonds have quite a bit more Mono than Polyunsaturates in them!

#95 oehaut

  • Guest
  • 393 posts
  • 20
  • Location:Canada

Posted 20 April 2010 - 01:10 PM

What is the correct ratio? I've been taking carnosine, but I'm thinking of switching to beta-alanine based on cost.



don't know. putting it on my list of things to do. might look it up this saturday.


It looks like beta-alanine deplete taurine. I can't find anything on a ratio, but the depletion is quite intense

The cytoprotective role of taurine in exercise-induced muscle injury.

Intense exercise is thought to increase oxidative stress and damage muscle tissue. Taurine is present in high concentration in skeletal muscle and may play a role in cellular defenses against free radical-mediated damage. The aim of this study was to determine if manipulating muscle levels of taurine would alter markers of free radical damage after exercise-induced injury. Adult male Sprague-Dawley rats were supplemented via the drinking water with either 3% (w/v) taurine (n = 10) or the competitive taurine transport inhibitor, beta-alanine (n = 10), for one month. Controls (n = 20) drank tap water containing 0.02% taurine and all rats were placed on a taurine free diet. All the rats except one group of sedentary controls (n = 10) were subjected to 90 minutes of downhill treadmill running. Markers of cellular injury and free radical damage were determined along with tissue amino acid content. The 3% taurine treatment raised plasma levels about 2-fold and 3% beta-alanine reduced plasma taurine levels about 50%. Taurine supplementation (TS) significantly increased plasma glutamate levels in exercised rats. Exercise reduced plasma methionine levels and taurine prevented its decline. Taurine supplementation increased muscle taurine content significantly in all muscles except the soleus. beta-alanine decreased muscle taurine content about 50% in all the muscles examined. Lipid peroxidation (TBARS) was significantly increased by exercise in the extensor digitorium longus (EDL) and gastrocnemius (GAST) muscles. Both taurine and beta-alanine completely blocked the increase in TBARs in the EDL, but had no effect in the GAST. Muscle content of the cytosolic enzyme, lactate dehydrogenase (LDH) was significantly decreased by exercise in the GAST muscle and this effect was attenuated by both taurine and beta-alanine. Muscle myeloperoxidase (MPO) activity was significantly elevated in the gastrocnemius muscle, but diet had no effect. MPO activity was significantly increased by exercise in the liver and both taurine and beta-alanine blocked this effect. There was no effect of either exercise or the diets on MPO activity in the lung or spleen. Running performance as assessed by a subjective rating scale was improved by taurine supplementation and there was a significant loss in body weight in the beta-alanine-treated rats 24 hours after exercise. In summary, taurine supplementation or taurine depletion had measurable cytoprotective actions to attenuate exercise-induced injury.



#96 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 26 April 2010 - 05:52 PM

Mech Ageing Dev. 2010 Jan;131(1):38-47. Epub 2009 Dec 3.

Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on age-related mitochondrial DNA deletion and oxidative stress of a MUFA-rich diet in rat heart.
Quiles JL, Pamplona R, Ramirez-Tortosa MC, Naudí A, Portero-Otin M, Araujo-Nepomuceno E, López-Frías M, Battino M, Ochoa JJ.

Institute of Nutrition and Food Technology José Mataix Verdú, Department of Physiology, University of Granada, Granada, Spain. jlquiles@ugr.es

Abstract
Age-related changes in cardiomyocytes reduce the capacity to recover from acute injury or to adapt during chronic disease in advanced age. N-6 polyunsaturated fatty acids (n-6PUFA) lead to higher lipid peroxidation during aging than the less oxidizable monounsaturated fatty acids (MUFA); and coenzyme Q (CoQ)-supplemented n-6PUFA lengthens the lifespan and reduces peroxidation in comparison to non-supplemented n-6PUFA. Here, lifelong feeding on MUFA, n-6PUFA, and n-6 PUFA+CoQ was compared regarding age-related alterations in rat heart. Less mitochondrial area and perimeter were reported for aged n-6 PUFA-fed animals while MUFA led to a higher density of mitochondrial cristae. Mitochondrial complexes and cytochrome c oxidase activity decreased with aging (except complex I and cytochrome c oxidase in n-6 PUFA+CoQ), while increased apoptosis-inducing factor was found with aging. MUFA led to lower mitochondrial DNA-deletion frequency. The lowest hydroperoxide levels for aged animals were found for n-6 PUFA+CoQ, which also showed lower concentrations than did n-6 PUFA. For protein oxidation, specific carbonyl compounds were lower in aged animals; meanwhile lipoxidation-derived protein-oxidation markers were higher. The results suggest that MUFA can protect mitochondria from age-related changes, and that CoQ supplementation to n-6 PUFA partially resembles MUFA benefits. Moreover, under our experimental conditions, lipid-derived oxidative damage appears to be more important than the pure protein-derived oxidative damage during aging. © 2009 Elsevier Ireland Ltd. All rights reserved.

PMID: 19948181 [PubMed - indexed for MEDLINE]



#97 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 26 April 2010 - 06:06 PM

I'm just going to post some studies I find interesting as usual. However their won't be links because I'm at work and it'll take too long.

FASEB J. 1991 Mar 1;5(3):344-53.
Unique fatty acid composition of normal cartilage: discovery of high levels of n-9 eicosatrienoic acid and low levels of n-6 polyunsaturated fatty acids.
Adkisson HD 4th, Risener FS Jr, Zarrinkar PP, Walla MD, Christie WW, Wuthier RE.
Department of Chemistry, University of South Carolina, Columbia 29208.

From this study fasting seems to release the LA
J Clin Invest. 1975 Jul;56(1):127-34.
The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally.
Wene JD, Connor WE, DenBesten L.

Am J Clin Nutr. 1977 Mar;30(3):388-93.
Absence of the biochemical symptoms of essential fatty acid deficiency in surgical patients undergoing protein sparing therapy.
Stegink LD, Freeman JB, Wispe J, Connor WE.

Prostaglandins Leukot Essent Fatty Acids. 1993 Jul;49(1):531-6.
Interaction between vitamin B6 deficiency and low EFA dietary intake on kidney phospholipids and PGE2 in the rat.
Maranesi M, Barzanti V, Coccheri S, Marchetti M, Tolomelli B.
Centro Ricerche sulla Nutrizione, Dipartimento di Biochimica, Bologna, Italia.

It seems that mead acid and LA interact a lot. I'm looking into this stuff because I have been looking over Ray Peat's stuff again. At first I dismissed his ideas, but the more I read the less "essential" the EFA's become. Anyways, I might be totally wrong (and I probably am) but I like thinking about it).

#98 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 29 April 2010 - 06:19 AM

Some interesting papers over at Sci.Life-Extension

EFAD protects kidneys

#99 e Volution

  • Guest
  • 937 posts
  • 280
  • Location:spaceship earth

Posted 29 April 2010 - 10:04 AM

I just wanted to say real interesting thread, I am so thankful you guys are fleshing this issue out for people like myself who can follow along on the sidelines but are not actually knowledgeable enough to partake in the investigation (yet) :p

In regards to the low carb & high fat VS moderate to high carb & low to moderate fat approaches, to those following the latter, how do you respond to the DukeNukem school of thought that carbs[insulin] = aging? Acknowledging my pro-paleo stance, Dr. Harris (PaNu) states the kernel of his theory is "Insulin is a phylogenetically old hormone. It is a biological messenger that in excess, is metabolically saying the following to your tissue and organs: "Go ahead and store energy, mature, reproduce and die."". I know this is a rather crude non-detail considering statement, but it seems most people here accept a similar crude/simple theory as to why CR works: hunkering down & survival mode, shift focus away from reproduction and instead on maintenance and repair for when food is more abundant, etc. Now I understand that the high carb & low fat is found in many long lived populations, so in that respect it is almost a sure thing in terms of longevity promotion, but I feel like we have the ability to go better than simply what works for X population and going directly to the science. And I think this is what is happening for example with PUFA. It doesn't really matter any more if X long lived population had a high PUFA consumption, or many studies showing benefit, the big picture is emerging that it would be advised to keep PUFA < 10%

I guess I thought we had the carb thing nailed, that basically the less insulin you have flow through your veins throughout your life, ceteris paribus, the better?

#100 kismet

  • Guest
  • 2,984 posts
  • 424
  • Location:Austria, Vienna

Posted 29 April 2010 - 12:28 PM

 

I guess I thought we had the carb thing nailed, that basically the less insulin you have flow through your veins throughout your life, ceteris paribus, the better?

All else being equal, perhaps. And who knows that all else is equal? Do you really think the only difference between fat and CHO boils down to insulin? That only insulin can drive aging and disease? Isn't this the epitome of simplification?  :p
That is among the reasons why good clinical data - where applicable - is usually unbeatable. No one really knows what the metabolic differences between macronutrients are and their implications.

People accept that CR "works" because until now that's what hundreds of well-designed studies in different species were showing. Not because they have a pet theory of how CR works. Mechanistic explanations strengthen a hypothesis and provide understanding, but usually not good evidence (they don't "prove" your hypothesis).

Edited by kismet, 29 April 2010 - 12:31 PM.


#101 oehaut

  • Guest
  • 393 posts
  • 20
  • Location:Canada

Posted 29 April 2010 - 12:45 PM

I just wanted to say real interesting thread, I am so thankful you guys are fleshing this issue out for people like myself who can follow along on the sidelines but are not actually knowledgeable enough to partake in the investigation (yet) :p

In regards to the low carb & high fat VS moderate to high carb & low to moderate fat approaches, to those following the latter, how do you respond to the DukeNukem school of thought that carbs[insulin] = aging? Acknowledging my pro-paleo stance, Dr. Harris (PaNu) states the kernel of his theory is "Insulin is a phylogenetically old hormone. It is a biological messenger that in excess, is metabolically saying the following to your tissue and organs: "Go ahead and store energy, mature, reproduce and die."". I know this is a rather crude non-detail considering statement, but it seems most people here accept a similar crude/simple theory as to why CR works: hunkering down & survival mode, shift focus away from reproduction and instead on maintenance and repair for when food is more abundant, etc. Now I understand that the high carb & low fat is found in many long lived populations, so in that respect it is almost a sure thing in terms of longevity promotion, but I feel like we have the ability to go better than simply what works for X population and going directly to the science. And I think this is what is happening for example with PUFA. It doesn't really matter any more if X long lived population had a high PUFA consumption, or many studies showing benefit, the big picture is emerging that it would be advised to keep PUFA < 10%

I guess I thought we had the carb thing nailed, that basically the less insulin you have flow through your veins throughout your life, ceteris paribus, the better?


Kismet gave you a pretty good and toughtful answer, as usual, and I simply want to add a little bit of what I've learned in my own parcour.

I used to believe that epidemiology did not mean squat (mislead by people who denies it because many epidemiological studies goes againsnt their hypothesis), and I was and still am largely & often speculating more than I should. Someone who I greatly respect here told me that it's about time that we understand that epidemiology on clinical end point (mortality, aging, pathology, etc) trumps any speculation we can have about a phenomenom. And indeed, i'm reading a very good book on critical appraisal of studies, and they say that epidemiology can indeed be use to prove causation, if you've got enough good quality studies showing the same result, because many things will never be able to be test in an experimental setting - so it's either epidemiology or speculation, you choose.

But I think you should trust more the fact that many population made it to a very high age and in good health on a high-carbs diet... it's a good hints, and even if it doens't show that carbs are healthy, it's probably show that they are not detrimental per se.

As for the PUFAs, that's why i'm trying to go with the epidemiology right now and think that PUFA can't be that bad, even will all the speculation we can make about it. After all, they keep lowering CHD incidence in many prospective cohort studies.

And as for the carbs=aging, a pelo-diet is probably usually higher in protein than a high-carb diet, and protein will stimulate many aging factor, such as IGF-1, leucine will stimulate mTOR-pathway, and probably other that i'm not aware of, such as the methionine issu that i've never took the time to dig.

A paleo diet is pro-anabolic, as demonstrated many time by peoples (myself included) who can shed fat and pack muscle while on it very efficiently. As I understand it, too much anabolism is pro aging.

As kismet said, I really don't think you can bring aging down to carbs and insulin. The real big picture is much, much more complicated than what we can understand by now.

Edited by oehaut, 29 April 2010 - 12:58 PM.


#102 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 25 May 2010 - 04:16 AM

In some of my readings I came across this paper:

Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions
Dietary -Linolenic Acid, EPA, and DHA Have Differential Effects on LDL Fatty Acid Composition but Similar Effects on Serum Lipid Profiles in Normolipidemic Humans

They have a very good table based on the fatty acid composition of LDL particles after 6 wks of supplementation: TBL5

This study I found on important factors that alter ARA metabolism:

Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):201-6. Epub 2009 Apr 8.
Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult men.
Angela Liou Y, Innis SM.

Nutrition Research Program, Child and Family Research Institute, Department of Paediatrics, University of British Columbia, 950 West 28th Avenue, Vancouver, B.C., V5Z 4H4, Canada.
Abstract
High intakes of linoleic acid (LA,18:2n-6) have raised concern due to possible increase in arachidonic acid (ARA, 20:4n-6) synthesis, and inhibition of alpha linolenic acid (ALA, 18:3n-3) desaturation to eicosapentaenoic (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). In healthy men, 10.5% energy compared to 3.8% energy LA with 1% energy ALA increased plasma phospholipid LA and 20:2n-6, the elongation product of LA, and decreased EPA, with no change in ARA. However, LA was inversely related to ARA at both 10.5% energy and 3.8% energy LA, (r=-0.761, r=-0.817, p<0.001, respectively). A two-fold variability in ARA among individuals was not explained by the dietary LA, ARA, ALA, or fish intake. Our results confirm LA requirements for ARA synthesis is low, <3.8% energy, and they suggest current LA intakes saturate Delta-6 desaturation and adversely affect n-3 fatty acid metabolism. Factors other than n-6 fatty acid intake are important modifiers of plasma ARA.

PMID: 19356914 [PubMed - indexed for MEDLINE]


Anyways, I have been trying to find ways of decreasing ARA. There's some interesting papers on the topic of the inflammatory properties of ARA metabolites such as:

If anyone has access to this paper that would be great:
A 'Desaturase Hypothesis' for Atherosclerosis: Janus-Faced Enzymes in -6 and -3 Polyunsaturated Fatty Acid Metabolism
Nicola Martinelli, Letizia Consoli, Oliviero Olivieri
Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy

Annu Rev Pharmacol Toxicol. 2009;49:123-50.
Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.
Shimizu T.

Department of Biochemistry and Molecular Biology, The University of Tokyo, Tokyo 113-0033, Japan. tshimizu@m.u-tokyo.ac.jp
Abstract
Prostaglandins, leukotrienes, platelet-activating factor, lysophosphatidic acid, sphingosine 1-phosphate, and endocannabinoids, collectively referred to as lipid mediators, play pivotal roles in immune regulation and self-defense, and in the maintenance of homeostasis in living systems. They are produced by multistep enzymatic pathways, which are initiated by the de-esterification of membrane phospholipids by phospholipase A2s or sphingo-myelinase. Lipid mediators exert their biological effects by binding to cognate receptors, which are members of the G protein-coupled receptor superfamily. The synthesis of the lipid mediators and subsequent induction of receptor activity is tightly regulated under normal physiological conditions, and enzyme and/or receptor dysfunction can lead to a variety of disease conditions. Thus, the manipulation of lipid mediator signaling, through either enzyme inhibitors or receptor antagonists and agonists, has great potential as a therapeutic approach to disease. In this review, I summarize our current state of knowledge of the synthesis of lipid mediators and the function of their cognate receptors, and discuss the effects of genetic or pharmacological ablation of enzyme or receptor function on various pathophysiological processes.

PMID: 18834304 [PubMed - indexed for MEDLINE]


One thing I think might work would be carnitine but I'll have to do some more research.

Edited by Sillewater, 25 May 2010 - 04:17 AM.


#103 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 25 May 2010 - 05:48 AM

Some interesting work regarding L-carnitine and ARA.

This study looks at older rats compared to younger rats and the plasma lipid profiles are different:

Biochem Biophys Res Commun. 1990 Jul 31;170(2):621-6.
Effect of aging and acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes.
Ruggiero FM, Cafagna F, Gadaleta MN, Quagliariello E.

Department of Biochemistry and Molecular Biology, University of Bari, Italy.
Abstract
The effect of aging and treatment with acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes was studied. It was found that aging increases the levels of free and esterified cholesterol. Fatty acid patterns in the plasma of aged rats show remarkable alterations when compared with control rats. These changes reverted to normal after three hours of acetyl-L-carnitine treatment. No significant differences in the erythrocyte lipid pattern of young and aged rats were observed. This study provides the first proof that acetyl-L-carnitine probably acts by lowering free and esterified cholesterol and arachidonic acid (20:4) levels in the plasma.

PMID: 2383260 [PubMed - indexed for MEDLINE]


Apparently ARA acid is 50% more in older rats and L-carnitine reverses that.

Also carnitine inhibits incorporation of ARA and release of ARA from platelets:

Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H41-8. Epub 2002 Sep 5.
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress.
Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I, Gazzaniga PP, Pulcinelli FM, Violi F.

Dipartimento di Medicina Sperimentale e Patologia, Università di Roma La Sapienza, Italy.
Abstract
Carnitine is a physiological cellular constituent that favors intracellular fatty acid transport, whose role on platelet function and O(2) free radicals has not been fully investigated. The aim of this study was to seek whether carnitine interferes with arachidonic acid metabolism and platelet function. Carnitine (10-50 microM) was able to dose dependently inhibit arachidonic acid incorporation into platelet phospholipids and agonist-induced arachidonic acid release. Incubation of platelets with carnitine dose dependently inhibited collagen-induced platelet aggregation, thromboxane A(2) formation, and Ca(2+) mobilization, without affecting phospholipase A(2) activation. Furthermore, carnitine inhibited platelet superoxide anion (O(2)(-)) formation elicited by arachidonic acid and collagen. To explore the underlying mechanism, arachidonic acid-stimulated platelets were incubated with NADPH. This study showed an enhanced platelet O(2)(-) formation, suggesting a role for NADPH oxidase in arachidonic acid-mediated platelet O(2)(-) production. Incubation of platelets with carnitine significantly reduced arachidonic acid-mediated NADPH oxidase activation. Moreover, the activation of protein kinase C was inhibited by 50 microM carnitine. This study shows that carnitine inhibits arachidonic acid accumulation into platelet phospholipids and in turn platelet function and arachidonic acid release elicited by platelet agonists.

PMID: 12388290 [PubMed - indexed for MEDLINE]Free Article



#104 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 27 May 2010 - 04:14 AM

Lancet. 1994 Oct 29;344(8931):1195-6.
Dietary polyunsaturated fatty acids and composition of human aortic plaques.
Felton CV, Crook D, Davies MJ, Oliver MF.
Wynn Institute for Metabolic Research, London, UK.

Abstract
How long-term dietary intake of essential fatty acids affects the fatty-acid content of aortic plaques is not clear. We compared the fatty-acid composition of aortic plaques with that of post-mortem serum and adipose tissue, in which essential fatty-acid content reflects dietary intake. Positive associations were found between serum and plaque omega 6 (r = 0.75) and omega 3 (r = 0.93) polyunsaturated fatty acids, and monounsaturates (r = 0.70), and also between adipose tissue and plaque omega 6 polyunsaturated fatty acids (r = 0.89). No associations were found with saturated fatty acids. These findings imply a direct influence of dietary polyunsaturated fatty acids on aortic plaque formation and suggest that current trends favouring increased intake of polyunsaturated fatty acids should be reconsidered.

PMID: 7934543 [PubMed - indexed for MEDLINE]



#105 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 29 May 2010 - 09:11 PM

Mech Ageing Dev. 2010 Jan;131(1):38-47. Epub 2009 Dec 3.
Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on age-related mitochondrial DNA deletion and oxidative stress of a MUFA-rich diet in rat heart.
Quiles JL, Pamplona R, Ramirez-Tortosa MC, Naudí A, Portero-Otin M, Araujo-Nepomuceno E, López-Frías M, Battino M, Ochoa JJ.

Institute of Nutrition and Food Technology José Mataix Verdú, Department of Physiology, University of Granada, Granada, Spain. jlquiles@ugr.es
Abstract
Age-related changes in cardiomyocytes reduce the capacity to recover from acute injury or to adapt during chronic disease in advanced age. N-6 polyunsaturated fatty acids (n-6PUFA) lead to higher lipid peroxidation during aging than the less oxidizable monounsaturated fatty acids (MUFA); and coenzyme Q (CoQ)-supplemented n-6PUFA lengthens the lifespan and reduces peroxidation in comparison to non-supplemented n-6PUFA. Here, lifelong feeding on MUFA, n-6PUFA, and n-6 PUFA+CoQ was compared regarding age-related alterations in rat heart. Less mitochondrial area and perimeter were reported for aged n-6 PUFA-fed animals while MUFA led to a higher density of mitochondrial cristae. Mitochondrial complexes and cytochrome c oxidase activity decreased with aging (except complex I and cytochrome c oxidase in n-6 PUFA+CoQ), while increased apoptosis-inducing factor was found with aging. MUFA led to lower mitochondrial DNA-deletion frequency. The lowest hydroperoxide levels for aged animals were found for n-6 PUFA+CoQ, which also showed lower concentrations than did n-6 PUFA. For protein oxidation, specific carbonyl compounds were lower in aged animals; meanwhile lipoxidation-derived protein-oxidation markers were higher. The results suggest that MUFA can protect mitochondria from age-related changes, and that CoQ supplementation to n-6 PUFA partially resembles MUFA benefits. Moreover, under our experimental conditions, lipid-derived oxidative damage appears to be more important than the pure protein-derived oxidative damage during aging. © 2009 Elsevier Ireland Ltd. All rights reserved.

PMID: 19948181 [PubMed - indexed for MEDLINE]


For those of us who do waiver from our diet and eat shit maybe some CoQ10 on hand would help.

#106 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 08 June 2010 - 04:40 AM

Mech Ageing Dev. 2010 Apr;131(4):242-52. Epub 2010 Feb 26.
Mitochondrial redox metabolism: aging, longevity and dietary effects.
Page MM, Robb EL, Salway KD, Stuart JA.
Department of Biological Sciences, Brock University, St. Catharines, ON, Canada.

Given the central role that cardiolipin appears to play in the mitochondrial apoptotic pathway, it is important to ask whether this phospholipid might be a useful target for modulating the aging process (see Pepe, 2005 for review). Cardiolipin is particularly susceptible to peroxidation because of its high content of unsaturated fatty acyl chains. In heart mitochondria, 80–90% of cardiolipin fatty acyl chains are linoleic acid (18:2n − 6). Lee et al. (2006) reported that the fatty acyl composition of heart mitochondrial cardiolipin is altered with age: 24-month-old rats have almost 35% less linoleic acid, and higher levels of the highly unsaturated arachadonic acid (20:4n − 6) and docosahexaenoic acid (22:6n − 3). These more highly unsaturated fatty acids are more susceptible to peroxidation. Cardiolipin linoleic acid content is amenable to dietary manipulation (for example, see Dannenberger et al., 2007). Dietary supplementation with linoleic acid can attenuate the age-related depletion of linoleic acid from rat heart mitochondrial cardiolipin, while improving overall heart function and resistance to oxidative challenges (Chicco et al., 2008). These results indicate that dietary supplementation is capable of promoting the incorporation of linoleic acid into cardiolipin, which may in turn be significant in maintaining mitochondrial function with age and thus perhaps promote longevity. More research into this possibility is therefore warranted.



#107 HaloTeK

  • Guest
  • 254 posts
  • 7
  • Location:chicago

Posted 08 June 2010 - 07:46 PM

Mech Ageing Dev. 2010 Apr;131(4):242-52. Epub 2010 Feb 26.
Mitochondrial redox metabolism: aging, longevity and dietary effects.
Page MM, Robb EL, Salway KD, Stuart JA.
Department of Biological Sciences, Brock University, St. Catharines, ON, Canada.

Given the central role that cardiolipin appears to play in the mitochondrial apoptotic pathway, it is important to ask whether this phospholipid might be a useful target for modulating the aging process (see Pepe, 2005 for review). Cardiolipin is particularly susceptible to peroxidation because of its high content of unsaturated fatty acyl chains. In heart mitochondria, 80–90% of cardiolipin fatty acyl chains are linoleic acid (18:2n − 6). Lee et al. (2006) reported that the fatty acyl composition of heart mitochondrial cardiolipin is altered with age: 24-month-old rats have almost 35% less linoleic acid, and higher levels of the highly unsaturated arachadonic acid (20:4n − 6) and docosahexaenoic acid (22:6n − 3). These more highly unsaturated fatty acids are more susceptible to peroxidation. Cardiolipin linoleic acid content is amenable to dietary manipulation (for example, see Dannenberger et al., 2007). Dietary supplementation with linoleic acid can attenuate the age-related depletion of linoleic acid from rat heart mitochondrial cardiolipin, while improving overall heart function and resistance to oxidative challenges (Chicco et al., 2008). These results indicate that dietary supplementation is capable of promoting the incorporation of linoleic acid into cardiolipin, which may in turn be significant in maintaining mitochondrial function with age and thus perhaps promote longevity. More research into this possibility is therefore warranted.


Interesting, this is showing a plus for omega 6s. This also seems to somewhat point to M. Rae's theory that DHA might be detrimental to absolute longevity.

#108 Sillewater

  • Guest
  • 1,076 posts
  • 280
  • Location:Canada
  • NO

Posted 16 June 2010 - 08:22 AM

Rejuvenation Res. 2009 Feb;12(1):25-32.
Plasma polyunsaturated fatty acids and age-related physical performance decline.
Abbatecola AM, Cherubini A, Guralnik JM, Andres Lacueva C, Ruggiero C, Maggio M, Bandinelli S, Paolisso G, Ferrucci L.
Department of Geriatric Medicine and Metabolic Diseases, Second University of Naples, Naples, Italy.
Abstract
Due to supporting evidence that dietary patterns may have a significant role in the maintenance of good physical performance with aging, we tested whether plasma fatty acids, saturated fatty acids (SFA), and polyunsaturated (PUFA) fatty acids are cross-sectionally associated with different physical performance and predict changes in physical performance over a 3-year period. Data were from the InCHIANTI study, a population-based study of older Italians. Plasma fatty acids were measured at enrollment (1998-2000), and outcome variables, Summary Physical Performance Battery (SPPB), and time to walk 7 meters (m) were measured at enrollment and after 3 years (2001-2004). At enrollment, 330 participants had significantly impaired lower extremity performance (defined as a SPPB score < or = 9). Adjusting for age, participants with a SPPB score > 9 had higher levels of total PUFA, n-3 PUFA, and n-6 PUFA, while significantly lower levels of SFA than those with a SPPB score < 9. Baseline SPPB scores were also associated with n-3 PUFA (beta = 0.148, p = 0.031), whereas the 7-m walk time was associated with total PUFA (beta = - 0.068, p = 0.008), after adjusting for potential confounders. Of the 884 participants with a SPPB score > 9 at baseline, 114 (12.9%) developed impaired lower extremity performance (SPPB < or = 9). In fully adjusted logistic models, baseline n-3 PUFA levels were inversely related to the risk of developing a decline in SPPB to < or = 9 (odds ratio [OR] = 0.21; 95% confidence interval [CI] = 0.08-0.53), while the n-6/n-3 ratio was associated with a higher risk of SPPB decline to < or = 9 (OR = 5.23; 95% CI = 2.02-13.51). In multivariate regression models, the n-6/n-3 ratio was associated with a longer time to walk 7 m (beta = 0.396, p = 0.037). n-3 PUFA plasma levels, which most likely reflect dietary intake, seem to protect against accelerated decline of physical performance. A higher n-6/n-3 ratio was associated with higher risk of developing poor physical performance and slower walking speed.
PMID: 19196012 [PubMed - indexed for MEDLINE]PMCID: PMC2674224Free PMC Article



#109 TheFountain

  • Guest
  • 5,362 posts
  • 257

Posted 16 June 2010 - 10:18 AM

Mech Ageing Dev. 2010 Jan;131(1):38-47. Epub 2009 Dec 3.
Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on age-related mitochondrial DNA deletion and oxidative stress of a MUFA-rich diet in rat heart.
Quiles JL, Pamplona R, Ramirez-Tortosa MC, Naudí A, Portero-Otin M, Araujo-Nepomuceno E, López-Frías M, Battino M, Ochoa JJ.

Institute of Nutrition and Food Technology José Mataix Verdú, Department of Physiology, University of Granada, Granada, Spain. jlquiles@ugr.es
Abstract
Age-related changes in cardiomyocytes reduce the capacity to recover from acute injury or to adapt during chronic disease in advanced age. N-6 polyunsaturated fatty acids (n-6PUFA) lead to higher lipid peroxidation during aging than the less oxidizable monounsaturated fatty acids (MUFA); and coenzyme Q (CoQ)-supplemented n-6PUFA lengthens the lifespan and reduces peroxidation in comparison to non-supplemented n-6PUFA. Here, lifelong feeding on MUFA, n-6PUFA, and n-6 PUFA+CoQ was compared regarding age-related alterations in rat heart. Less mitochondrial area and perimeter were reported for aged n-6 PUFA-fed animals while MUFA led to a higher density of mitochondrial cristae. Mitochondrial complexes and cytochrome c oxidase activity decreased with aging (except complex I and cytochrome c oxidase in n-6 PUFA+CoQ), while increased apoptosis-inducing factor was found with aging. MUFA led to lower mitochondrial DNA-deletion frequency. The lowest hydroperoxide levels for aged animals were found for n-6 PUFA+CoQ, which also showed lower concentrations than did n-6 PUFA. For protein oxidation, specific carbonyl compounds were lower in aged animals; meanwhile lipoxidation-derived protein-oxidation markers were higher. The results suggest that MUFA can protect mitochondria from age-related changes, and that CoQ supplementation to n-6 PUFA partially resembles MUFA benefits. Moreover, under our experimental conditions, lipid-derived oxidative damage appears to be more important than the pure protein-derived oxidative damage during aging. © 2009 Elsevier Ireland Ltd. All rights reserved.

PMID: 19948181 [PubMed - indexed for MEDLINE]


For those of us who do waiver from our diet and eat shit maybe some CoQ10 on hand would help.


The only time I really waiver is when I am out somewhere and occasionally settle for chinese or mexican food. The rice, tortilla chips (which are generally made with 0-6 rich oils) and/or wraps are generally what I feel bad about eating (I usually get the vegetables plain without sauce). But once every 2 or 3 weeks isn't going to cause any permanent insulin response. And On those days I try to take extra glycation inhibitors and anti-inflammatory supplements. I would prefer never eating out but ocassionally a stupid social setting seems to necessitate it.

Edited by TheFountain, 16 June 2010 - 10:19 AM.


#110 TheFountain

  • Guest
  • 5,362 posts
  • 257

Posted 16 June 2010 - 10:22 AM

Some interesting work regarding L-carnitine and ARA.

This study looks at older rats compared to younger rats and the plasma lipid profiles are different:

Biochem Biophys Res Commun. 1990 Jul 31;170(2):621-6.
Effect of aging and acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes.
Ruggiero FM, Cafagna F, Gadaleta MN, Quagliariello E.

Department of Biochemistry and Molecular Biology, University of Bari, Italy.
Abstract
The effect of aging and treatment with acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes was studied. It was found that aging increases the levels of free and esterified cholesterol. Fatty acid patterns in the plasma of aged rats show remarkable alterations when compared with control rats. These changes reverted to normal after three hours of acetyl-L-carnitine treatment. No significant differences in the erythrocyte lipid pattern of young and aged rats were observed. This study provides the first proof that acetyl-L-carnitine probably acts by lowering free and esterified cholesterol and arachidonic acid (20:4) levels in the plasma.

PMID: 2383260 [PubMed - indexed for MEDLINE]


Apparently ARA acid is 50% more in older rats and L-carnitine reverses that.

Also carnitine inhibits incorporation of ARA and release of ARA from platelets:

Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H41-8. Epub 2002 Sep 5.
Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress.
Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I, Gazzaniga PP, Pulcinelli FM, Violi F.

Dipartimento di Medicina Sperimentale e Patologia, Università di Roma La Sapienza, Italy.
Abstract
Carnitine is a physiological cellular constituent that favors intracellular fatty acid transport, whose role on platelet function and O(2) free radicals has not been fully investigated. The aim of this study was to seek whether carnitine interferes with arachidonic acid metabolism and platelet function. Carnitine (10-50 microM) was able to dose dependently inhibit arachidonic acid incorporation into platelet phospholipids and agonist-induced arachidonic acid release. Incubation of platelets with carnitine dose dependently inhibited collagen-induced platelet aggregation, thromboxane A(2) formation, and Ca(2+) mobilization, without affecting phospholipase A(2) activation. Furthermore, carnitine inhibited platelet superoxide anion (O(2)(-)) formation elicited by arachidonic acid and collagen. To explore the underlying mechanism, arachidonic acid-stimulated platelets were incubated with NADPH. This study showed an enhanced platelet O(2)(-) formation, suggesting a role for NADPH oxidase in arachidonic acid-mediated platelet O(2)(-) production. Incubation of platelets with carnitine significantly reduced arachidonic acid-mediated NADPH oxidase activation. Moreover, the activation of protein kinase C was inhibited by 50 microM carnitine. This study shows that carnitine inhibits arachidonic acid accumulation into platelet phospholipids and in turn platelet function and arachidonic acid release elicited by platelet agonists.

PMID: 12388290 [PubMed - indexed for MEDLINE]Free Article


Yea I definitely have to re-incorporate ALCAR into my regimen. I haven't taken it in a couple months due to finance. But I think I may incorporate it again starting next week. It's just one of those supplements where the benefits preclude your regimen from missing it.




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users